Daiichi Sankyo US

Daiichi Sankyo US

Share

We create life-changing solutions for patients. See our community guidelines: https://bit.ly/4fLkZS8

At Daiichi Sankyo, we create essential medicine for longer, better lives. By uniting cutting edge science and technology with a genuine interest in people, we develop high quality, life changing solutions for the patients of today and tomorrow with great care and unwavering dedication.

Our success comes from experts in collaboration: our people, scientists, health care providers, advocates and patients themselves. Every partner on our journey, each passionately bringing their own skills and insights to bear, is essential. We seek out the patient voice and incorporate it into what we do each day, so that our continuous investment in cancer treatment research can make the biggest possible difference.

Building on 125+ years of experience, we’re leveraging our world-class science and technology to help create better futures for people with cancer, cardiovascular, and other diseases with high unmet medical need. Together, we are creating new standards of care, our contribution to the enrichment of quality of life around the world.

Safety Information:
Please call the Daiichi Sankyo Contact Center at 1-877-4DS-PROD (1-877-437-7763) if you have a question about any of our products or to report any adverse reactions to our products. To report negative side effects of prescription drugs to the FDA, visit www.fda.gov/medwatch.

Photos from Daiichi Sankyo US's post 11/05/2026

What can a career beyond academia look like for a PhD?

We recently welcomed students from Yale University to Daiichi Sankyo for a Job Trek focused on exploring careers in the pharmaceutical industry. Students heard about different career journeys, learned how their skills and experiences can translate into opportunities in industry, and made connections to help grow their professional networks.

By creating opportunities for students to learn directly from our people, we’re helping emerging talent explore what’s possible and discover new paths for their future.

NSCLC: Understanding the Treatment Journey 11/03/2026

Every lung cancer journey is different.

For people living with non-small cell lung cancer (NSCLC), individual factors such as tumor biology and biomarker test results can help inform treatment decisions. And when the disease changes, the treatment journey may change, too.

🔗 Read our latest article: https://bit.ly/3UChNCO

And learn more about the disease, how biomarker testing can shape treatment options and the advances in research.

NSCLC: Understanding the Treatment Journey Explore how biomarker testing guides advanced NSCLC treatment, why treatment paths differ and how research aims to address unmet needs in lung cancer.

Complexity and Grace in Clinical Trial Operations 10/20/2026

“The details matter because the people matter.”

Even though Senior Study Associate Tara Rowek may never meet the patients whose lives could be affected by her work, she still feels part of their journey.

And a deep responsibility to ensure the studies here at Daiichi Sankyo are conducted with the highest level of quality.

👉 Read her full story and more about clinical trials here: https://bit.ly/4i9Eypk

Complexity and Grace in Clinical Trial Operations Learn how Daiichi Sankyo move clinical trials forward with quality, collaboration and patient focus.

10/06/2026

An early breast cancer diagnosis can bring difficult questions - but it can also create important opportunities to learn. Our research is helping scientists better understand tumor response, recurrence risk, and how advances in care may support patients earlier in their journey, when treatment is often given with curative intent.

Read more here: https://bit.ly/3TnBygX

At Daiichi Sankyo, we are committed to asking more of science and pushing innovation across the different stages of breast cancer to help address unmet needs for patients and their loved ones.

Photos from Daiichi Sankyo US's post 09/24/2026

Research has the power to deepen our understanding of cancer and open the door to new possibilities for patients. 🔬

is a reminder of that power and the unmet need that still exists.

At Daiichi Sankyo we continue to push research and evaluate new therapies and treatment options for patients including the potential of HER2-directed therapies in endometrial and ovarian cancers. Learn more here: https://bit.ly/4yePTew

09/21/2026

What happens behind the scenes of clinical trials?

Advancing potential new medicines requires collaboration across science, quality, compliance, clinical operations, and more. For Tara Rowek, helping teams navigate that complexity starts with grace.

Having supported her own mother through a breast cancer diagnosis, Tara understands that behind every scientific advancement are people searching for hope, answers and more moments together. It's a perspective that continues to shape her craft of grace.

🎥 Watch Tara's story and discover how her craft of grace is helping turn possibility into progress. https://bit.ly/4yrWaDp

No One Succeeds Alone: Dalal Nesheiwat on Mentorship, Resilience and Seizing Opportunity 08/31/2026

“She left behind everything she had ever known.”

The most important leadership lessons don't always begin in the workplace. For Dalal Nesheiwat, they began with her mother. At just 16 years old, she left her home country to build a new life in the United States. Through perseverance, resilience, and the encouragement of those who believed in her, she created opportunities that would shape not only her own future, but also her daughter's approach to leadership.

Those early lessons inspired Dalal to embrace opportunities, seek out mentors, and invest in the next generation of leaders. Read more about the people, experiences, and values that continue to shape her leadership journey and outcomes for patients.

👉 Read the full story:

No One Succeeds Alone: Dalal Nesheiwat on Mentorship, Resilience and Seizing Opportunity As a proud first-generation Jordanian American, Dalal Nesheiwat learned early on that resilience is strengthened by those who believe in you. Discover how those lessons shaped her leadership journey and why she's committed to paying that support forward.

07/27/2026

“I do not follow the status quo. I create my own path.”

For Dalal Nesheiwat, that mindset has shaped a career dedicated to advancing research and innovation in pursuit of better outcomes for people around the world.

As a global R&D leader at Daiichi Sankyo, she found a culture where she can bring her authentic self to work, contribute her unique perspective, and help shape what's possible for the future of healthcare. Through her leadership and commitment to mentoring the next generation of leaders and pharmacy students, Dalal is helping others forge paths of their own.

🎥 Watch Dalal's story and discover how her craft of pathfinding is helping turn possibility into progress.

The CARE Team Philosophy: What It Is and How It Supports Cancer Care 07/22/2026

No one should face cancer alone.

Behind every patient is a network of healthcare professionals, advocates, caregivers and loved ones working together to provide support, guidance and care.

At Daiichi Sankyo, our CARE Team model is built around Collaboration, Accountability, Respect and Ex*****on; principles that help us support oncology practices, healthcare professionals and patient communities.

📖Read more about our CARE Team philosophy and our commitment to patients and their full support system: https://bit.ly/4yFIOoe

The CARE Team Philosophy: What It Is and How It Supports Cancer Care Cancer care is never carried out by one person alone. It is a team effort, with oncologists, nurses, pharmacists, pathologists, patient support teams, caregivers, and many others all supporting the patient.

07/10/2026

How does AI impact patients? Over 80 patient advocacy group leaders gathered during to share insights during the second annual Daiichi Sankyo Patient Summit.

Through presentations and a panel discussion, participants explored the limitations of AI and how to navigate its evolving role in healthcare responsibly through transparency, data security, human oversight, and training.

Key takeaways from the summit panelists:

- Anjee Davis, CEO of Fight Colorectal Cancer, shared the Fight CRC team’s successful use of AI to identify gaps in care and improve healthcare processes.

- Dr. Jody Britten delivered an important reminder that not everyone is ready for AI, and that support must be provided for patients who cannot access, lack confidence, or do not trust these tools.

💬 How do you think AI can best help?

Want your practice to be the top-listed Clinic in Basking Ridge?
Click here to claim your Sponsored Listing.

Address


211 Mt. Airy Road
Basking Ridge, NJ
07920

Other Pharmaceutical Companies in Basking Ridge

Show All
Lisata Therapeutics, Inc. Lisata Therapeutics, Inc.
Basking Ridge

Targeted Therapy Delivered

Alerts

Be the first to know and let us send you an email when Daiichi Sankyo US posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Subscribe

We will notify you when anything happens in Basking Ridge.